Results 171 to 180 of about 4,889,938 (291)

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Paradoxical sex differences in a hamster model of angiotensin II-dependent hypertension and associated renal injury. [PDF]

Biol Sex Differ
Ji H, Nascimento LGD, Ahn J, Kwon DH, Williams G, Wu X, Speth RC, Hawks SA, Duggal NK, Saavedra JM, Sandberg K, de Souza AMA.   +11 more
europepmc   +1 more source

Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India

, 2014
AnanthaNaik Nagappa, Rajesh Balkrishnan, Uday Venkat Mateti   +2 more
openalex   +1 more source

Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anesthetized water-deprived rat. [PDF]

, 1981
Charles E. Andrews, B M Brenner
openalex   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

LARP1 acts as a key mediator in preventing angiotensin II-induced cardiac dysfunction and fibrosis. [PDF]

Cell Biosci
Zheng H, Yang C.
europepmc   +1 more source

Angiotensin II

Hospital Pharmacy, 2018
Danial E. Baker, Terri L. Levien
semanticscholar   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Angiotensin II in Catecholamine-Refractory Shock: A Systematic Review and Exploratory Analysis of the Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Trial. [PDF]

Cureus
Khallikane S, Qamouss Y, Elabdi M, Bouzerda A, Khatouri A, Zyani M, Seddiki R.   +6 more
europepmc   +1 more source

-78-THE EFFECT OF RAT ATRIOPEPTIN III ON RAT GLOMERULAR ANGIOTENSIN II RECEPTOR PROPERTIES AND PLASMA ANGIOTENSIN II CONCENTRATION IN NORMOTENSIVE WISTAR-KYOTO AND SPONTANEOUSLY HYPERTENSIVE RATS

, 1986
Noriyuki Kohashi, Francis E. Cole, N. C. Trippodo, Allan A. MacPhee, Edward D. Fröhlich   +4 more
openalex   +2 more sources